CERE
Cerevel Therapeutics Holdings Inc

3,251
Loading...
Loading...
Latest Earnings Results: Q2 '24
Reported: Nov 01

Estimated EPS

-$0.71

Reported EPS

---

Surprise

---

Estimated Rev

$0M

Reported Rev

---

Surprise

---

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '24
-$0.72
--
--
N/A
Q2 '24
-$0.71
--
--
N/A
Q1 '24
-$0.71
--
--
N/A
Q4 '23
-$0.71
--
--
N/A
Q3 '23
-$0.63
-$0.61
2.74%
BEAT

Latest CERE News

View

Advertisement. Remove ads.

Advertisement. Remove ads.